6:20 PM
 | 
Jun 15, 2016
 |  BC Extra  |  Financial News

Antibiotic play Allecra raises EUR 22M

Allecra Therapeutics GmbH (Lorrach, Germany) raised EUR 22 million ($24.8 million) in an untranched series B round led by new investor Delos Capital. Existing investors Forbion Capital Partners, Edmond de Rothschild Investment Partners, EMBL...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >